UPDATE: Please note that the lawyers at Saiontz & Kirk, P.A. are no longer taking on new cases involving Avandia. The content on this page is provided for informational purposes only.

The diabetes drug Avandia has been linked to an increased risk of serious and potentially fatal injuries. The Avandia lawyers at Saiontz & Kirk, P.A. previously pursued lawsuits on behalf of users who suffered some of the following problems linked to this diabetes drug:

  • Heart Attack
  • Stroke
  • Liver Failure
  • Heart Failure
  • Bone Fractures
  • Vision Loss (Macular Edema)
  • Death

>>LEARN MORE: Avandia Lawsuits


Avandia (generic rosiglitazone) is a medication prescribed to treat Type 2 diabetes. It was approved on May 25, 1999, and was used by over 6 million people worldwide before it was discovered that it may be unreasonably dangerous.

Research has suggested that users of the drug face an increased risk of heart attacks, congestive heart failure, bone fractures, liver failure, macular edema and cardiovascular related death.

>>LEARN MORE: Avandia Side Effects

For years, GlaxoSmithKline PLC failed to adequately warn consumers or disclose the risks of serious and potentially fatal injuries with Avandia. Experts have suggested that as many as 200,000 heart attacks could have been caused by Avandia, and many of those could have been prevented if proper warnings were provided.

In 2006, Avandia sales were over $2.2 billion in the United States, and many believe the manufacturer failed to disclose the heart attack risks out of fear that it would negatively impact sales.

Since information regarding the Avandia heart risk was reported in the New England Journal of Medicine on May 21, 2007, GlaxoSmithKline has seen sales fall substantially and the diabetes drug was largely abandoned by the medical community.

The FDA has required that a prominently displayed ‘black box’ warning be added to the drug indicating an increased risk of congestive heart failure and heart attacks, and access to the medication was severely restricted starting in 2011. While some of those restrictions were lifted in December 2015, the medication now carries strong warnings about the potential Avandia health risks.

>>LEARN MORE: Time Line of Avandia Heart Problems